Atherosclerosis Research

Atherosclerosis is a disease of the arterial system that is characterized by the accumulation of fatty deposits within arterial walls, known as 'atherosclerotic plaques'.

Atherosclerosis Research Products Targets

Products for Atherosclerosis Research

Cat.No. Product Name Information/Activity
BCC5019 Benazepril HCl Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure.
BCC2140 Captopril Captopril (SQ-14534) is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
BCC5015 Moexipril HCl Moexipril hydrochloride is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure.
BCC3586 Perindopril Erbumine Perindopril erbumine (Perindopril tert-butylamine salt) is a potent ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease.
BCC2349 Spinorphin Enkephalin-degrading and ACE inhibitor
BCC1004 Angiotensin I (human, mouse, rat) Angiotensin 1 (Human) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).
BCC5807 Hemopressin (rat) 568588-77-2
BCC5018 Aliskiren Hemifumarate Aliskiren hemifumarate(CGP 60536 hemifumarate) is a direct renin inhibitor with IC50 of 1.5 nM.
BCC3944 A 205804 A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.
BCC3946 A 286982 Potent inhibitor of the LFA-1/ICAM-1 interaction